Current / Ongoing Studies                                                                                                        updated May 2020

No Study Name/Phase Type Sponsor Population (Gender/Age) Enrolled Period
1 HPV vaccine /Phase III HPV vaccine MSD ♀ 9-26 yrs 20 2010 – 2020
2 Menacwy/Phase III Meningococcal vaccine Pfizer ♂/♀ 12-14 M 86 2014 – 2020
3 HDT TB/Phase IIb TB Treatment Aurum Institute ♂/♀ 18-65 yrs 39 2016 – 2020
4 HVTN 702/Phase IIb HIV Vaccine HVTN ♂/♀18-35 yrs 468 2017 – 2021
5 HVTN 705/Phase IIb HIV Vaccine Janssen/HVTN ♀18-35 yrs 144 2018 – 2021
6 NC008/Phase IIc TB Treatment TB Alliance ♂/♀≥18 19 2018 – 2020
7 PrEPARE Study/PrEP Rollout PrEP RTI ♀16-24 yrs  n/a 2019 – 2021
8 MV40618/Phase IIIb Flu treatment (Adults) Roche ♂/♀Index – 12-64 yrsHousehold – ≥2 yrs 0 2019 – 2020
9 EPI RSV RSV study GSK ♀ 18-45 100 2019 – 2020
10 TB Migration study TB Tracing John Hopkins University ♂/♀ 0-99 yrs 0 2020 – 2025